A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia.
about
Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancyEmerging technologies in paediatric leukaemiaZNF423 and ZNF521: EBF1 Antagonists of Potential Relevance in B-Lymphoid MalignanciesRedefining ALL classification: toward detecting high-risk ALL and implementing precision medicineCurrent concepts in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemiaComprehensive genomic analysis reveals FLT3 activation and a therapeutic strategy for a patient with relapsed adult B-lymphoblastic leukemiaChildhood acute lymphoblastic leukemia: Integrating genomics into therapyChildhood Acute Lymphoblastic Leukemia: Progress Through CollaborationA novel BCR-ABL1 fusion gene identified by next-generation sequencing in chronic myeloid leukemia.A Comprehensive Review of Pediatric Tumors and Associated Cancer Predisposition Syndromes.Germline ETV6 Mutations Confer Susceptibility to Acute Lymphoblastic Leukemia and Thrombocytopenia.Germline ETV6 mutations and predisposition to hematological malignancies.Non-infectious chemotherapy-associated acute toxicities during childhood acute lymphoblastic leukemia therapy.The prenatal origins of cancerChildhood B-acute lymphoblastic leukemia: a genetic update.Pax5 loss imposes a reversible differentiation block in B-progenitor acute lymphoblastic leukemia.Outcomes of children with BCR-ABL1–like acute lymphoblastic leukemia treated with risk-directed therapy based on the levels of minimal residual disease.Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia.Germline genetic variation in ETV6 and risk of childhood acute lymphoblastic leukaemia: a systematic genetic study.Biology of childhood acute lymphoblastic leukemia.PAX5 is a tumor suppressor in mouse mutagenesis models of acute lymphoblastic leukemia.Association of E26 Transformation Specific Sequence 1 Variants with Rheumatoid Arthritis in Chinese Han PopulationInherited genetic variation in childhood acute lymphoblastic leukemia.Ebf1 heterozygosity results in increased DNA damage in pro-B cells and their synergistic transformation by Pax5 haploinsufficiencyTissue-Specific Enrichment of Lymphoma Risk Loci in Regulatory Elements.Genome-wide analysis links NFATC2 with asparaginase hypersensitivity.An integrated analysis tool for analyzing hybridization intensities and genotypes using new-generation population-optimized human arrays.Diversity of human and mouse homeobox gene expression in development and adult tissues.Altered neutrophil immunophenotypes in childhood B‑cell precursor acute lymphoblastic leukemia.Genomic characterization of childhood acute lymphoblastic leukemia.Deep targeted sequencing in pediatric acute lymphoblastic leukemia unveils distinct mutational patterns between genetic subtypes and novel relapse-associated genes.Cancer genomics and inherited risk.PAX genes in childhood oncogenesis: developmental biology gone awry?Genetically engineered mouse models of human B-cell precursor leukemias.Genomic and pharmacogenetic studies of childhood acute lymphoblastic leukemia.X-linked agammaglobulinemia associated with B-precursor acute lymphoblastic leukemia.Genomics in acute lymphoblastic leukaemia: insights and treatment implications.Transcription factor networks in B-cell differentiation link development to acute lymphoid leukemia.Therapies on the horizon for childhood acute lymphoblastic leukemia.Single nucleotide polymorphisms in clinics: Fantasy or reality for cancer?
P2860
Q24314163-1EF40793-0D40-48AA-9EF2-CE5D7589028EQ26770327-37F6A1BA-9C56-4158-8380-6C3BCD3A2F2AQ26770729-FE45FB0A-4EE5-41BA-989F-B81639AD4F35Q26864460-5BF36128-9BDC-4538-9E4E-525600DD4E99Q27025242-2107E70A-180E-4F1C-A5BA-8C304273577EQ27853385-76A29D00-82F4-42CE-BF7F-562CCF588AA6Q28080463-0A110424-48E9-47E7-848A-9F85700E72D9Q28087637-A7B6778A-E2B3-40A9-A6F4-8D9371DB1BEFQ30008897-1202FFF2-4836-43F8-8704-BBF12AD85734Q30252766-C768F337-7A6F-492C-A481-A1919E13A4B2Q33423823-AA83F8F6-824D-4278-925C-CCCBFBB373B1Q33442207-DB258D46-A370-483B-A1D3-3B754BE0EA60Q33557148-8ED9ADC5-0B21-480F-A05F-E8938DA22D1BQ33697463-BECA729F-D3A0-4436-BB96-70567B81CFBEQ33777616-B33288E4-E3E0-406B-8C98-CB49975E4760Q33789597-B85AB6DE-AF53-42A9-8974-E4CA2E3863EBQ34172033-5322FDC1-890C-4B3E-A60C-5116D3C2F335Q34314927-65D0C714-67E4-4DBD-968A-31420E16A412Q34500075-6E813B67-497A-490C-A49C-E6A92797D6BFQ34605953-539A2325-5BB8-42E6-8141-C0AE43F664E4Q35692410-5BDEE2EE-5BA6-40F6-AF3B-3A9A09797B33Q35737609-D15B3D93-0D2B-4CB2-AC1A-7A4480EAAF83Q35784497-98C1285A-9DF9-4AD6-B336-4A6B3F55B138Q35784511-206ABB9C-4DC3-4147-A782-F9C98E02618AQ35793648-683551D4-7F97-4CE6-88A4-FD68612BE5C3Q35820373-4B2968FE-4DE2-4C10-9A82-A1A60AC2DE03Q35974493-B06FB3DA-00EC-4304-B445-0D083AAD5113Q36181281-1C5D4746-4AE6-42C2-A02C-91CBED795CA7Q37269402-832EBC6E-2A98-4CD2-8E5F-6C7FE0F6E6C9Q37359118-157D545E-EB9D-45B4-8086-7A9B4EF6348CQ37665574-69C2F2D2-A8D6-4656-B917-B9EFEC2B367DQ38180646-6B568F8B-61B4-4B88-B5CB-03960BD965A9Q38231866-7822C8CD-E438-44E7-8E02-418241CAB1A3Q38285177-A611FA66-7961-47F1-B827-BEF350930CC4Q38289596-7DEF3F24-10A1-4210-BF33-18C43E06F7AAQ38319601-66C64F75-88E6-41DC-ACAA-690A619FE24BQ38381463-138B25DC-7277-4BBD-AD70-BFB91D207A38Q38492313-4765BF95-A6E1-41B6-978E-F0825F70BDF6Q38504437-0B029721-0452-48E3-AB41-939817C0B9E0Q38591731-4C1AAD4F-591F-4711-9CDC-47136A809511
P2860
A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia.
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
A recurrent germline PAX5 muta ...... acute lymphoblastic leukemia.
@ast
A recurrent germline PAX5 muta ...... acute lymphoblastic leukemia.
@en
A recurrent germline PAX5 muta ...... acute lymphoblastic leukemia.
@nl
type
label
A recurrent germline PAX5 muta ...... acute lymphoblastic leukemia.
@ast
A recurrent germline PAX5 muta ...... acute lymphoblastic leukemia.
@en
A recurrent germline PAX5 muta ...... acute lymphoblastic leukemia.
@nl
prefLabel
A recurrent germline PAX5 muta ...... acute lymphoblastic leukemia.
@ast
A recurrent germline PAX5 muta ...... acute lymphoblastic leukemia.
@en
A recurrent germline PAX5 muta ...... acute lymphoblastic leukemia.
@nl
P2093
P2860
P50
P356
P1433
P1476
A recurrent germline PAX5 muta ...... acute lymphoblastic leukemia.
@en
P2093
Agnes Viale
Andrew E Timms
Annet Simons
Christopher Manschreck
Christopher N Hahn
Cornelius Miething
David G Huntsman
David Wheeler
Deborah Ritter
Esmé Waanders
P2860
P2888
P304
P356
10.1038/NG.2754
P407
P50
P577
2013-09-08T00:00:00Z
P5875
P6179
1039413904